benzylpenicilloyl polylysine
Drug data last refreshed 17h ago · AI intelligence enriched Yesterday
PRE-PEN is a diagnostic agent containing benzylpenicilloyl polylysine, used as a skin test reagent to assess penicillin allergy status in patients. It functions as a hapten-carrier complex that binds to IgE antibodies specific to penicillin metabolites, enabling detection of Type I hypersensitivity reactions. This injectable formulation helps clinicians identify true penicillin allergy before prescribing beta-lactam antibiotics.
This product is approaching loss of exclusivity with minimal commercial infrastructure, suggesting a small, potentially declining team focused on maintenance and transition planning rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on PRE-PEN offers limited career growth due to its niche diagnostic market and approaching LOE status. This role suits professionals seeking stability in legacy product management or those building expertise in transition planning and portfolio wind-down strategies.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.